These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11205293)

  • 1. An elevated serum level of transforming growth factor-beta 1 (TGF-beta 1) significantly correlated with lymph node metastasis and poor prognosis in patients with gastric carcinoma.
    Saito H; Tsujitani S; Oka S; Kondo A; Ikeguchi M; Maeta M; Kaibara N
    Anticancer Res; 2000; 20(6B):4489-93. PubMed ID: 11205293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of transforming growth factor beta1 are significantly correlated with venous invasion in patients with gastric cancer.
    Lin Y; Kikuchi S; Obata Y; Yagyu K;
    J Gastroenterol Hepatol; 2006 Feb; 21(2):432-7. PubMed ID: 16509870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of TGF beta 1 and TGF beta 3 in human breast carcinoma.
    Ghellal A; Li C; Hayes M; Byrne G; Bundred N; Kumar S
    Anticancer Res; 2000; 20(6B):4413-8. PubMed ID: 11205281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma.
    Hasegawa Y; Takanashi S; Kanehira Y; Tsushima T; Imai T; Okumura K
    Cancer; 2001 Mar; 91(5):964-71. PubMed ID: 11251948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters.
    Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
    J Surg Oncol; 2007 Feb; 95(2):123-8. PubMed ID: 17262742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum concentration of CD44 variant 6 and its relation to prognosis in patients with gastric carcinoma.
    Saito H; Tsujitani S; Katano K; Ikeguchi M; Maeta M; Kaibara N
    Cancer; 1998 Sep; 83(6):1094-101. PubMed ID: 9740073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional lymph node metastasis as a predictor of peritoneal carcinomatosis in patients with Borrmann type IV gastric carcinoma.
    Otsuji E; Yamaguchi T; Sawai K; Sakakura C; Okamoto K; Takahashi T
    Am J Gastroenterol; 1999 Feb; 94(2):434-7. PubMed ID: 10022642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating transforming growth factor beta 1 as a predictor of liver metastasis after resection in colorectal cancer.
    Tsushima H; Ito N; Tamura S; Matsuda Y; Inada M; Yabuuchi I; Imai Y; Nagashima R; Misawa H; Takeda H; Matsuzawa Y; Kawata S
    Clin Cancer Res; 2001 May; 7(5):1258-62. PubMed ID: 11350892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant overexpression of cyclooxygenase-2 in HER-2-positive on Smad4-reduced human gastric carcinomas is associated with a poor patient outcome.
    Okano H; Shinohara H; Miyamoto A; Takaori K; Tanigawa N
    Clin Cancer Res; 2004 Oct; 10(20):6938-45. PubMed ID: 15501972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus.
    Natsugoe S; Xiangming C; Matsumoto M; Okumura H; Nakashima S; Sakita H; Ishigami S; Baba M; Takao S; Aikou T
    Clin Cancer Res; 2002 Jun; 8(6):1838-42. PubMed ID: 12060625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of epidermal growth factor receptor in the serum of gastric carcinoma patients.
    Choi JH; Oh JY; Ryu SK; Kim SJ; Lee NY; Kim YS; Yi SY; Shim KS; Han WS
    Cancer; 1997 May; 79(10):1879-83. PubMed ID: 9149012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum human hepatocyte growth factor (hHGF) is elevated in patients with metastatic gastric carcinoma.
    Niki M; Isozaki H; Toyoda M; Ishibashi T; Fujii K; Nomura E; Mabuchi H; Nakamura M; Nishiguchi K; Tanigawa N
    Hepatogastroenterology; 1998; 45(24):2458-63. PubMed ID: 9951944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum level of transforming growth factor-beta1 (TGF-beta1) and the expression of TGF-beta receptor type II in peripheral blood mononuclear cells in patients with autoimmune hepatitis.
    Sakaguchi K; Kitano M; Nishimura M; Senoh T; Ohta T; Terao M; Shinji N; Koide N; Tsuji T
    Hepatogastroenterology; 2004; 51(60):1780-3. PubMed ID: 15532825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relations of transforming growth factor-beta1 expression to differentiation and prognosis of advanced gastric cancer].
    Guo RF; Zang SZ; Zhang L; Li WM; Hu FL; Lü YY
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3249-54. PubMed ID: 17313802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated plasma TGF-beta1 levels correlate with decreased survival of metastatic breast cancer patients.
    Ivanović V; Demajo M; Krtolica K; Krajnović M; Konstantinović M; Baltić V; Prtenjak G; Stojiljković B; Breberina M; Nesković-Konstantinović Z; Nikolić-Vukosavljević D; Dimitrijević B
    Clin Chim Acta; 2006 Sep; 371(1-2):191-3. PubMed ID: 16650397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of lymph node metastasis by size of early gastric carcinoma.
    Otsuji E; Kuriu Y; Ichikawa D; Ochiai T; Okamoto K; Yamagishi H
    Hepatogastroenterology; 2007 Mar; 54(74):602-5. PubMed ID: 17523331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of serum transforming growth factor beta 1 in detecting of gastric and colon cancers.
    Coban S; Yüksel O; Koçkar MC; Köklü S; Basar O; Tutkak H; Ormeci N
    Hepatogastroenterology; 2007; 54(77):1472-6. PubMed ID: 17708279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence in early gastric cancer--presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence.
    Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
    Hepatogastroenterology; 2007 Mar; 54(74):620-4. PubMed ID: 17523336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex of urokinase-type plasminogen activator with its type 1 inhibitor predicts poor outcome in 576 patients with lymph node-negative breast carcinoma.
    Manders P; Tjan-Heijnen VC; Span PN; Grebenchtchikov N; Geurts-Moespot A; van Tienoven DT; Beex LV; Sweep FC
    Cancer; 2004 Aug; 101(3):486-94. PubMed ID: 15274061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.